Praxis Precision Medicines (PRAX) Tops Q1 EPS by 40c

Praxis Precision Medicines (NASDAQ: PRAX) reported Q1 EPS of ($3.20), $0.40 better than the analyst estimate of ($3.60).

For earnings history and earnings-related data on Praxis Precision Medicines (PRAX) click here.

You May Also Be Interested In

• Dyadic International, Inc. (DYAI) Misses Q2 EPS by 2c
• Sutro Biopharma Inc. (STRO) Misses Q2 EPS by 13c
• Performance Food Group (PFGC) Misses Q4 EPS by 1c ; Offers Guidance